🔗 Share this article

Texas Attorney General Paxton is filing a lawsuit against the producers of Tylenol, claiming the corporations hid safety concerns that the medication posed to pediatric cognitive development.

The court filing comes thirty days after President Donald Trump publicized an unverified association between consuming Tylenol - alternatively called paracetamol - throughout gestation and autism spectrum disorder in offspring.

The attorney general is taking legal action against the pharmaceutical giant, which once produced the drug, the only pain reliever approved for pregnant women, and the current manufacturer, which currently produces it.

In a official comment, he stated they "deceived the public by making money from discomfort and promoting medication ignoring the risks."

The manufacturer says there is insufficient reliable data tying Tylenol to autism.

"These manufacturers misled for generations, intentionally threatening numerous people to boost earnings," Paxton, from the Republican party, stated.

Kenvue stated officially that it was "very worried by the perpetuation of misinformation on the safety of acetaminophen and the potential impact that could have on the well-being of US mothers and children."

On its website, the company also stated it had "regularly reviewed the relevant science and there is insufficient valid information that indicates a verified association between taking paracetamol and autism spectrum disorder."

Groups speaking for medical professionals and health professionals share this view.

The American College of Obstetricians and Gynecologists has said paracetamol - the primary component in Tylenol - is a restricted selection for expectant mothers to address pain and elevated temperature, which can create major wellness concerns if left untreated.

"In more than two decades of investigation on the use of acetaminophen in gestation, not a single reputable study has successfully concluded that the use of acetaminophen in any period of pregnancy causes neurological conditions in children," the group commented.

This legal action cites recent announcements from the Trump administration in asserting the drug is allegedly unsafe.

Recently, the former president caused concern from public health officials when he advised expectant mothers to "fight like hell" not to take acetaminophen when sick.

The FDA then published an announcement that physicians should consider limiting the consumption of Tylenol, while also stating that "a direct connection" between the drug and autism in minors has not been proven.

Health Secretary RFK Jr, who manages the FDA, had vowed in spring to initiate "extensive scientific investigation" that would identify the cause of autism spectrum disorder in a matter of months.

But specialists cautioned that discovering a sole reason of autism - considered by experts to be the outcome of a complicated interplay of genetic and surrounding conditions - would not be simple.

Autism spectrum disorder is a form of lifelong neurodivergence and disability that affects how persons experience and relate to the world, and is identified using doctors' observations.

In his legal document, the attorney general - who supports Trump who is campaigning for federal office - alleges Kenvue and Johnson & Johnson "deliberately disregarded and attempted to silence the evidence" around paracetamol and autism.

The case seeks to make the companies "destroy any marketing or advertising" that states acetaminophen is safe for expectant mothers.

The Texas lawsuit parallels the complaints of a assembly of guardians of young ones with autism and ADHD who filed suit against the producers of Tylenol in two years ago.

The court rejected the lawsuit, saying studies from the plaintiffs' authorities was lacking definitive proof.